SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-000409
Filing Date
2022-01-06
Accepted
2022-01-06 09:31:41
Documents
3
Period of Report
2022-01-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164147948805268.html 4  
1 FORM 4 wf-form4_164147948805268.xml 4 5406
2 LIMITED POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS poastephendavis7-13x2015.htm EX-24 3305
3 POWER OF ATTORNEY ex-24.htm EX-24 3160
  Complete submission text file 0001628280-22-000409.txt   13354
Mailing Address ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400 SAN DIEGO CA 92130
Business Address
DAVIS STEPHEN (Reporting) CIK: 0001131146 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36783 | Film No.: 22513798

Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations